SAXENA PARAG - 27 Jun 2025 SCHEDULE 13D/A Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH)

Filing Manager: SAXENA PARAG
Reporting Manager: Parag Saxena
Security: REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value
Symbol: RVPH
Shares outstanding: 71,951,793 shares
Disclosed Ownership: 6,259,806 shares
Ownership: 8.7%
Form type: SCHEDULE 13D/A
Filing time: 01 Jul 2025, 18:40:00 UTC
Date of event: 27 Jun 2025
Previous filing: 31 Jan 2025
Next filing: 24 Sep 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vedanta Associates, L.P.	4.8%	3,408,401	0	3,408,401	By: Vedanta Partners, LLC, the GP of Vedanta Associates, L.P. /s/ Parag Saxena	Parag Saxena/CEO of Vedanta Partners, LLC	0001502222
VEDANTA PARTNERS, LLC	7.5%	5,367,069	0	5,367,069	/s/ Parag Saxena	Parag Saxena/CEO	0001502216
Parag Saxena	8.7%	6,259,806	892,737	5,376,169	/s/ Parag Saxena	Parag Saxena/Individual	0001015823